Herborium Group, Inc. (HBRM) Targeting the Acne Market
One of the markets that is currently very lucrative is one that Herborium Group, Inc. has chosen to target. The company is involved in botanical therapeutics(R) and has developed an acne treatment that is herbal and effective.
According to recent posts, the acne market is a $3.3 billion market for over the counter treatments. The product AcnEase(R) is a dermatological product that has undergone clinical testing. The results of the clinical testing were very positive and showed 95% of adolescent and young adult acne favorably responded while 80% effectiveness was seen in those 31 years old and older. Overall, these are very promising numbers and shows that Herborium Group Inc., has a chance to impact that $3.3 billion market. The product can be seen at: www.acnease.com.
Another opportunity has made itself present in the acne market as well. One of the most noted solutions to severe acne problems will be discontinuing the distribution and manufacturing of their product, Accutane(R). Accutane has been noted to have very severe side effects including skin dryness, Eczema, Muscle Pain, Depression, Liver Damage, Allergic reaction and even a flare up in acne.
With these types of side effects, this leaves a lot of room for a company such as Herborium Group, Inc. to come in and offer something that is safe and effective. The market is further increased when you consider the different areas where AcnEase(R) can be used such as in the cosmeceutical market and in other healthcare professional fields which totals over a $50 billion industry.
With the minds of consumers shifting into the natural and “green” ways of life, this is a perfect complement to an acne treatment. The company focuses on delivering an item that will be safe for people to use while reaping the benefits of clearer skin.
Based on recent press releases, the company looks to generate around $7 million in revenues within the next 12 months. They look to further their position in the market in the year 2011 to include revenues of $14 million which is double 2010 goals. The profit margins on this type of product are significant and we feel getting in on the ground level will prove to be a wise choice as an investor.
We don’t often come across penny stocks this undiscovered with established products. We think HBRM could be a big winner and we hope to hear more from the company soon on the progress it has been making. The company has been relatively quiet since December (there last PR is HERE) but we have noticed some accumulation and some slight price appreciation over the past month. We think based on these factors its time to starting watching HBRM very closely.
HBRM is only one of two “stocks we love” for the month of May, 2010! We think May will be kind indeed to both of these picks!








